PACB vs STE · rev $38.4M vs P/E 25, rev $5.46B
Pacific Biosciences of California (PACB) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
PACB currently screens at market cap $387.1M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the PACB and STE stock pages for the full models.
Not investment advice.